Jane Street
HRTX icon

Jane Street’s Heron Therapeutics HRTX Stock Holding History

Jane Street’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-29,200
Closed -$167K – 10133
2022
Q1 		$167K Sell
29,200
-90,300
-76% -$661K ﹤0.01% 9151
2021
Q4 		$1.09M Buy
119,500
+98,100
+458% +$1M ﹤0.01% 5714
2021
Q3 		$229K Sell
21,400
-7,000
-25% -$85.2K ﹤0.01% 8652
2021
Q2 		$441K Buy
28,400
+10,200
+56% +$162K ﹤0.01% 7474
2021
Q1 		$295K Buy
+18,200
New +$324K ﹤0.01% 7729
2020
Q4 		– Sell
-11,800
Closed -$175K – 7733
2020
Q3 		$175K Sell
11,800
-33,000
-74% -$515K ﹤0.01% 6510
2020
Q2 		$659K Buy
+44,800
New +$736K ﹤0.01% 4661

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Jane Street's HRTX Position: Q1 2026 in Review

Jane Street sold out of Heron Therapeutics (HRTX) in Q1 2026, closing a stake of 1,367,891 shares — an estimated $1.59M sold.

Jane Street first reported a position in HRTX in Q1 2014 and held it in 35 quarters. The position peaked at $1.78M in Q4 2025. 167 funds tracked by Wall St. Rank hold HRTX as of Q1 2026.

  • Jane Street reported no remaining Heron Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 1,367,891 Heron Therapeutics shares in Q1 2026, an estimated $1.59M.
  • Jane Street first reported a position in Heron Therapeutics in Q1 2014 and held it in 35 quarters.
  • Jane Street's Heron Therapeutics position peaked at $1.78M in Q4 2025.
  • 167 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.